Ignite Creation Date:
2024-06-16 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06451497
Status:
RECRUITING
Last Update Posted:
2024-06-11
First Post:
2024-05-14
Brief Title:
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
Sponsor:
Zumutor Biologics Inc
Organization:
Zumutor Biologics Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Diffuse Large B Cell Lymphoma |
| Non Small Cell Lung Cancer |
| Esophageal Cancer |
| Head and Neck Squamous Cell Carcinoma |
| Pancreas Adenocarcinoma |
| Biliary Tract Cancer |
| Prostate Cancer |
| Urothelial Carcinoma |
| Colorectal Cancer |
| Triple Negative Breast Cancer |
| High Grade Ovarian Serous Adenocarcinoma |
Keywords: